ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 142 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,042,000 | -11.2% | 2,794,428 | +37.3% | 0.00% | 0.0% |
| Q4 2021 | $2,300,000 | +2.9% | 2,035,885 | +65.8% | 0.00% | 0.0% |
| Q3 2021 | $2,235,000 | -30.8% | 1,227,702 | +0.4% | 0.00% | 0.0% |
| Q2 2021 | $3,228,000 | +2.6% | 1,222,760 | +39.9% | 0.00% | 0.0% |
| Q1 2021 | $3,147,000 | +39.7% | 873,932 | -2.3% | 0.00% | 0.0% |
| Q4 2020 | $2,253,000 | -10.2% | 894,064 | -10.2% | 0.00% | 0.0% |
| Q3 2020 | $2,508,000 | -28.4% | 995,277 | -6.8% | 0.00% | 0.0% |
| Q2 2020 | $3,505,000 | +76.4% | 1,068,450 | +31.8% | 0.00% | 0.0% |
| Q1 2020 | $1,987,000 | -42.2% | 810,872 | +11.4% | 0.00% | 0.0% |
| Q4 2019 | $3,435,000 | +9.1% | 727,765 | -1.1% | 0.00% | 0.0% |
| Q3 2019 | $3,148,000 | -22.3% | 735,622 | +5.9% | 0.00% | -50.0% |
| Q2 2019 | $4,051,000 | – | 694,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 17,815,708 | $47,033,000 | 2.93% |
| Essex Woodlands Management, Inc. | 2,764,908 | $7,130,000 | 2.60% |
| Belmont Global Advisors, Inc. | 973,000 | $2,569,000 | 2.01% |
| Belmont Global Advisors, Inc. | 135,700 | $358,000 | 0.28% |
| MSD Partners, L.P. | 2,750,000 | $7,260,000 | 0.22% |
| SFMG, LLC | 99,850 | $264,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,090 | $29,000 | 0.03% |
| WESTPORT RESOURCES MANAGEMENT INC | 33,500 | $88,000 | 0.02% |
| SMITH ASSET MANAGEMENT GROUP LP | 236,590 | $625,000 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 41,150 | $109,000 | 0.02% |